CP
XRAY icon

Castleview Partners’s Dentsply Sirona XRAY Stock Holding History

Castleview Partners’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-377
Closed -$10.2K – 621
2024
Q3 		$10.2K Buy
377
+108
+40% +$2.76K 0.01% 539
2024
Q2 		$6.7K Buy
269
+101
+60% +$2.9K ﹤0.01% 584
2024
Q1 		$5.58K Buy
168
+59
+54% +$2.02K ﹤0.01% 618
2023
Q4 		$3.88K Buy
+109
New +$3.46K ﹤0.01% 614
2022
Q3 		– Sell
-10
Closed -$22 – 774
2022
Q2 		$22 Sell
10
-153
-94% -$6.19K ﹤0.01% 757
2022
Q1 		$8K Sell
163
-64,314
-100% -$3.4M 0.01% 525
2021
Q4 		$1.16K Buy
+64,477
New +$3.55M 0.01% 369
2021
Q2 		$73K Buy
+1,156
New +$76.1K 0.03% 341

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Castleview Partners's XRAY Position: Q4 2024 in Review

Castleview Partners sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 377 shares — an estimated $10.2K sold.

Castleview Partners first reported a position in XRAY in Q2 2021 and held it in 8 quarters. The position peaked at $73K in Q2 2021. 359 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

  • Castleview Partners reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
  • Castleview Partners sold 377 Dentsply Sirona shares in Q4 2024, an estimated $10.2K.
  • Castleview Partners first reported a position in Dentsply Sirona in Q2 2021 and held it in 8 quarters.
  • Castleview Partners's Dentsply Sirona position peaked at $73K in Q2 2021.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Castleview Partners's 13F filing for Q4 2024, filed 21 Jan 2025.